Search company, investor...

Predict your next investment

Venture Capital
seroba-lifesciences.com

Investments

42

Portfolio Exits

5

Funds

1

About Seroba Life Sciences

Seroba Life Sciences, fka Seroba Kernel Life Sciences, is a European venture capital firm that invests across the spectrum of the life science industry including medical devices, biotechnology, specialty pharmaceuticals, therapeutic drugs, medical technology, diagnostics, instrumentation, and other selected opportunities. Seroba funds new healthcare opportunities through key value-adding stages, from inception through development and clinical evaluation, the generation of intellectual property, regulatory approvals and market launch, and partnering pharmaceutical or medtech companies.

Headquarters Location

6 Northbrook Road Ranelagh

Dublin, D06 PH32,

Ireland

+353 (0)1 633 4028

Want to inform investors similar to Seroba Life Sciences about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Seroba Life Sciences News

Deciphex Raises €3.9M in Funding

Jan 25, 2023

Deciphex , a Dublin, Ireland-based provider of pathology software and services, raised €3.9M in funding. The round was led by Seroba Life Sciences and existing investors. Jennifer McMahon, a partner with Seroba, will join the Board of Deciphex. The company intends to use the funds to continue developing its products and services, to expand its presence in the UK, Canada, the Middle East and the US, and to strengthen its position in the field of digital pathology and AI. Led by CEO Donal O’Shea, Deciphex offers a range of services for clinical and research pathology, including its Patholytix platform for research pathology. Its Diagnostics as a service platform, Diagnexia, connects laboratories to an international network of subspeciality pathologists, who can provide their expertise on clinical cases, while reducing turnaround times and ensuring the delivery of the highest quality of patient care. Commenting on the news, Donal O’Shea said: “This additional investment will allow us to continue to grow and innovate, solidifying our position as a leader in the field of pathology. We are committed to helping pathologists deliver the best possible care to patients through the use of cutting-edge technology.“ FinSMEs

Seroba Life Sciences Investments

42 Investments

Seroba Life Sciences has made 42 investments. Their latest investment was in Deciphex as part of their Series B - II on January 1, 2023.

CBI Logo

Seroba Life Sciences Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/23/2023

Series B - II

Deciphex

$4.24M

Yes

Seroba Life Sciences, and Undisclosed Investors

7

12/14/2022

Series B

STORM Therapeutics

$30M

No

6

10/4/2022

Series A

Sibylla Biotech

$22.68M

Yes

8

2/9/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

1/20/2022

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/23/2023

12/14/2022

10/4/2022

2/9/2022

1/20/2022

Round

Series B - II

Series B

Series A

Series A

Series C

Company

Deciphex

STORM Therapeutics

Sibylla Biotech

Subscribe to see more

Subscribe to see more

Amount

$4.24M

$30M

$22.68M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Seroba Life Sciences, and Undisclosed Investors

Sources

7

6

8

10

10

Seroba Life Sciences Portfolio Exits

5 Portfolio Exits

Seroba Life Sciences has 5 portfolio exits. Their latest portfolio exit was PQ Bypass on April 13, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/13/2021

Acquired

$99M

5

6/26/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

9/7/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

3/16/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

8/25/2014

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/13/2021

6/26/2020

9/7/2018

3/16/2018

8/25/2014

Exit

Acquired

IPO

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

10

10

10

10

Seroba Life Sciences Fund History

1 Fund History

Seroba Life Sciences has 1 fund, including Seroba Life Sciences Fund III.

Closing Date

Fund

Fund Type

Status

Amount

Sources

2/2/2017

Seroba Life Sciences Fund III

$108.08M

3

Closing Date

2/2/2017

Fund

Seroba Life Sciences Fund III

Fund Type

Status

Amount

$108.08M

Sources

3

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.